© 2009 American Public Health Association DOI: 10.2105/AJPH.2008.152900
Sonja A. Rasmussen, Janet D. Cragan, and Jennifer Williams are with the Division of Birth Defects and Developmental Disabilities, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA. Denise J. Jamieson, Kitty MacFarlane, and Zsakeba Henderson are with the Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta. Correspondence: Correspondence should be sent to Sonja A. Rasmussen, MD, MS, 1600 Clifton Rd, MS E-86, CDC, Atlanta, GA 30333 (e-mail: skr9{at}cdc.gov). Reprints can be ordered by visiting http://www.ajph.org and clicking on the "Reprints/Eprints" link.
Pandemic Influenza: Special Considerations for Pregnant Women was a meeting convened by the Centers for Disease Control and Prevention in 2008 to obtain input from experts and key partners regarding clinical management of pregnant women and related public health actions to be taken during a pandemic. Meeting goals were to discuss issues specific to pregnant women, identify gaps in knowledge, and develop a public health approach for pregnant women in the event of a pandemic. The meeting focused on 4 main topics: prophylaxis and treatment with influenza antiviral and other medications, vaccine use, nonpharmaceutical interventions and health care planning, and communications. Participants reviewed the available evidence to guide action in each of these areas and identified areas of critical needs for future research. This article has been cited by other articles:
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||